Interaction between CRHR1 and BDNF genes increases the risk of recurrent major depressive disorder in Chinese population

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Xiao, Zheman ^a   Liu, Wanhong ^b   Gao, Kai ^c   Wan, Qirong ^c   Yang, Can ^c   Wang, Huiling ^c   Wang, Xiaoping ^c   Wang, Gaohua ^a,c   Liu, Zhongchun ^a,c  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; CHINESE; CONTROLLED STUDY; CRH RECEPTOR 1 GENE; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; REGULATOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASIAN; BIOLOGICAL MODEL; CASE CONTROL STUDY; CHINA; GENETIC EPISTASIS; GENETIC PREDISPOSITION; GENETICS; MULTIFACTOR DIMENSIONALITY REDUCTION; RECURRENT DISEASE; RISK FACTOR;

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 1;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; CHINA; DEPRESSIVE DISORDER, MAJOR; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MODELS, GENETIC; MULTIFACTOR DIMENSIONALITY REDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECURRENCE; RISK FACTORS;

EID: 83355172854     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028733     Document Type: Article

References (36)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CS, Hughes M, et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States, Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8-19.
2. Duffy A, Grof P, Pobertson C, Alda M, (2000) The implications of genetics studies of major mood disorders for clinical practice. J Clin Psychiatry 61: 630-637.
3. Levinson DF, (2006) The genetics of depression: a review. Biol Psychiatry 60: 84-92.
4. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, et al. (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109: 143-148.
5. Schule C, Zill P, Baghai TC, Eser D, Zwanzger P, et al. (2006) Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients. Psychoneuroendocrinology 31: 1019-25.
6. Lezoualc'h F, Engert S, Berning B, Behl C, (2000) Corticotropin-releasing hormone mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB. Mol Endocrinol 14: 147-159.
7. Hauger RL, Risbrough V, Oakley RH, Olivares-Reyes JA, Dautzenberg FM, (2009) Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann N Y Acad Sci 1179: 120-143.
8. Bayatti N, Hermann H, Lutz B, Behl C, (2005) CRH-mediated induction of intracellular signaling pathways and BDNF expression is inhibited by the activation of the endocannabinoid system. Endocrinology 146: 1205-1213.
9. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB, (1996) Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 17: 166-172.
10. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, et al. (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428: 191-212.
11. Galter D, Unsicker K, (2000) Brain-derived neurotrophic factor and trkB are essential for cAMP-mediated induction of the serotonergic neuronal phenotype. J Neurosci Res 61: 295-301.
12. Ghosh A, Carnahan J, Greenberg ME, (1994) Requirement for BDNF in activity dependent survival of cortical neurons. Science 263: 1618-1623.
13. Licinio J, O'kirwan F, Irizarry K, Merriman B, Thakur S, et al. (2004) Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Mol Psychiatry 9: 1075-1082.
14. Liu ZC, Zhu F, Wang GH, Xiao ZM, Wang HL, et al. (2006) Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression. Neurosci Lett 404: 358-362.
15. Liu ZC, Zhu F, Wang GH, Xiao ZM, Tang JH, et al. (2007) Association study of corticotrophin releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders. Neurosci Lett 414: 155-158.
16. Ressler KJ, Bradley B, Mercer KB, Deveau TC, Smith AK, et al. (2010) Polymorphisms in CRHR1 and the serotonin transporter loci: gene×gene×environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet 153B: 812-824.
17. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
18. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, et al. (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant induced behavioral effects. J Neurosci 23: 349-357.
19. Duman RS, Monteggia LM, (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127.
20. Carlborg O, Haley CS, (2004) Epistasis: too often neglected in complex trait studies. Nature, 5: 618-625.
21. Holmans P, Zubenko GS, Crowe RR, DePaulo JJ, Scheftner WA, et al. (2004) Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am J Hum Genet 74: 1154-1167.
22. Zubenko GS, Zubenko WN, Spiker DG, Giles DE, Kaplan BB, (2001) Malignancy of recurrent early-onset major depression: a family study. Am J Med Genet 105: 690-699.
23. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, et al. (2006) The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Agin 27: 1834-1837.
24. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, et al. (2005) BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30: 1353-1361.
25. Oswald P, Del-Favero J, Massat I, Souery D, Claes S, et al. (2005) No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: evidence from Belgian first and replication patient-control studies. Eur Neuropsychopharmacol 15: 491-495.
26. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, et al. (2005) Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 58: 307-314.
27. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ, (2003) Association study of a brain derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Gene123B: 19-22.
28. Botto LD, Khoury MJ, (2001) Commentary: facing the challenge of gene environment interaction: the two-by-four table and beyond. Am J Epidemiol 153: 1016-1020.
29. Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, et al. (2006) BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59: 812-815.
30. American-Psychiatric-Association, (1994) Diagnostic and Statistical Manual of Mental Disorders (4th ed). American Psychiatric Association: Washington, DC.
31. Guy W, (1976) ECDEU Assessment Manual for Psychopharmacology Revised. pp. 218-221 Washington DC, US Department of Health, Education, and Welfare.
32. Hamilton M, (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278-296.
33. Miller SA, Dykes DD, Polesky HF, (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
34. Raymond M, Rousset F, (1995) GENEPOP (version 1.2). Population genetics software for exact tests and ecumenicism. J Hered 86: 248-249.
35. Schneider S, Roessli D, Excoffier L, (2000) Arlequin: a software for population genetics data analysis, Ver. 2.000 University of Geneva.
36. Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, et al. (2007) A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 80: 1125-1137.